.jpg?width=2000&height=400&name=R01_HLS%20GO%20KB45%20PeripheralVascular_061125_JY_AK2%20(1).jpg "R01_HLS GO KB45 PeripheralVascular_061125_JY_AK2 (1)")
Peripheral Vascular Devices Industry: A $6 Billion Race to Lead in Innovation and Outcomes
From peripheral artery disease (PAD) to chronic limb-threatening ischemia (CLTI), drug-eluting and bioresorbable technologies are transforming care pathways. Will your organization lead the charge?
Market Momentum
PAD affects 200+ million people globally — but with low screening and diagnosis rates, this market remains vastly underpenetrated. As demand for minimally invasive, endovascular interventions soars, the industry is shifting toward:
- Drug-eluting Stents (DES)
- Drug-coated Balloons (DCBs)
- Bioresorbable Scaffolds
- Advanced Imaging and Robotics
Projected Market Value:
- From $4.3 billion in 2024 to $6.06 billion in 2029
- CAGR: 6.9%
Download Sample
Strategic Insights You Will Gain
Technology Intelligence
• First-in-human milestones (e.g., ChampioNIR, Esprit BTK)
• R3 Vascular’s IDE-backed MAGNITUDE trial
• Positive long-term results from Abbott’s bioresorbable portfolio
Opportunities to Act On
• Growth in below-the-knee interventions for chronic limb-threatening ischemia (CLTI)
• Clinical adoption in ambulatory surgical centers (ASCs)
• Innovation gaps in resorbable scaffolds and device-drug synergy
Competitive Landscape
• Market share and positioning of Boston Scientific, Abbott, BD, Medtronic, and emerging disruptors
• Strategic M&A activity: Acotec, Cardiovascular Systems Inc.
Sign up for a complimentary Growth Pipeline Dialog™
A Growth Pipeline Dialog is a structured discussion with our growth experts providing unparalleled technology intelligence and proven implementation best practices. This discussion will spark innovative thinking and help generate a pipeline of growth opportunities you can leverage to maximize your company’s future growth potential.
Upon completing the dialog session, you will receive a $1,000 honorarium* as a token of our appreciation, which can be used towards the purchase of our products and services on store.frost.com.
*$1,000 honorarium is subject to eligibility
